Nodular Episcleritis in a Boy with Pulmonary Tuberculosis
Downloads
Introduction: Episcleritis is an acute inflammation of the vascular connective tissue between the conjunctiva and the sclera's surface, which can be found unilateral and bilateral. Tuberculosis (TB) is one of the systemic infectious diseases that cause morbidity in developing countries and can affect the ocular area known as ocular tuberculosis There are still limited cases of ocular tuberculosis studies, specifically tubercular nodular episcleritis in adolescents. This case report aims to expose nodular episcleritis in pediatric tuberculosis patients in Indonesia. Case Presentation: A 16-year-old boy came to the Community Eye Health Hospital East Java with superior bilateral eye redness and pain with normal visual acuity. He underwent advanced anti-tubercular treatment for the last nine months. The best corrected visual acuity (BCVA) of both eyes was 6/6. Slit-lamp biomicroscopy (SLB) examination found the dilation of blood vessels located on the superior episclera accompanied by a firmly bordered, fixed, pink nodule, diameter ± 1.5 mm located at 12 o'clock in bilateral bulbar conjunctiva. Based on anamnesis and physical examination, the diagnosis of nodular episcleritis et causa pulmonary TB was established. Topical corticosteroids and artificial tears eyedrops were given in both eyes for five weeks, and continuing anti-tubercular treatment was performed. Conclusion: It is necessary to investigate the primary cause of episcleritis by eliminating underlying systemic diseases. Herein, we present a rare case of nodular episcleritis in an adolescent with pulmonary tuberculosis who responded very well to anti-tubercular treatment with topical corticosteroid and artificial tears eye drops.
Xu TT, Reynolds MM, Hodge DO, Smith WM. Epidemiology and clinical characteristics of episcleritis and scleritis in Olmsted County, Minnesota. Am J Ophthalmol 2020;217:317–324. https://doi.org/10.1016/j.ajo.2020.04.043.
Akpek EK, Uy HS, Christen W, Gurdal C, Foster CS. Severity of episcleritis and systemic disease association. Ophthalmology 1999;106:729–731. https://doi.org/10.1016/S0161-6420(99)90157-4.
Schonberg S, Stokkermans TJ. Episcleritis. StatPearls, Tampa, United States: StatPearls; 2022.
Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology 2012;119:43–50. https://doi.org/10.1016/j.ophtha.2011.07.013.
Ilyas S, Yulianti SR. Ilmu Penyakit Mata. 5th ed. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia; 2018.
Riordan-Eva P, Augsburger JJ. Vaughan & Asbury's General Ophthalmology. 19th ed. New York: McGraw-Hill Education; 2017.
Weisenthal RW, Daly MK, de Freitas D, Feder RS, Orlin SE, Tu EY, et al., editors. Section 08: External Disease and Cornea. American Academy of Ophthalmology; 2020.
Basu S, Elkington P, Rao NA. Pathogenesis of ocular tuberculosis: New observations and future directions. Tuberculosis 2020;124:101961. https://doi.org/https://doi.org/10.1016/j.tube.2020.101961.
Thadani SM, Foster CS. Treatment of ocular inflammation in children. Paediatr Drugs 2004;6:289–301. https://doi.org/10.2165/00148581-200406050-00003.
Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010;149:562–570. https://doi.org/10.1016/j.ajo.2009.11.020.
Division of Tuberculosis Elimination. Treatment for TB Disease. Centers Dis Control Prev 2022. https://www.cdc.gov/tb/topic/treatment/tbdisease.htm (accessed November 1, 2022).
Abdisamadov A, Tursunov O. Ocular tuberculosis epidemiology, clinic features and diagnosis: A brief review. Tuberculosis 2020;124:101963. https://doi.org/https://doi.org/10.1016/j.tube.2020.101963.
Mehta S, Mansoor H, Khan S, Saranchuk P, Isaakidis P. Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis in Mumbai, India: a cross-sectional study. BMC Infect Dis 2013;13:225. https://doi.org/10.1186/1471-2334-13-225.
Gupta V, Shoughy SS, Mahajan S, Khairallah M, Rosenbaum JT, Curi A, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm 2015;23:14–24. https://doi.org/10.3109/09273948.2014.986582.
Porwal A. Rare presentation of nodular episcleritis with tuberculosis in a 12 year old girl: A case report. Delhi J Ophthalmol 2021;31:93–95. https://doi.org/10.7869/djo.666.
Astari P. Tuberkulosis intraokular. Nusant Med Sci J 2019;4:1. https://doi.org/10.20956/nmsj.v4i1.4684.
Bathula BP, Pappu S, Epari SR, Palaparti JB, Jose J, Ponnamalla PK. Tubercular nodular episcleritis. Indian J Chest Dis Allied Sci 2012;54:135–136.
Rao S. Tuberculosis and patient gender: An analysis and its implications in tuberculosis control. Lung India 2009;26:46–47. https://doi.org/10.4103/0970-2113.48897.
Yadav S, Rawal G. Tubercular nodular episcleritis: A case report. J Clin Diagn Res 2015;9:ND01-2. https://doi.org/10.7860/JCDR/2015/15023.6335.
Copyright (c) 2022 Rizki Matta Handayani, Niken Indah Noerdiyani, Indriani Kartika Dewi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
